Results 141 to 150 of about 146,730 (293)

Partial extravenous course of cardiac pacemaker leads. A major risk during device-assisted extraction

HeartRhythm Case Reports, 2015
Jean-Sylvain Hermida, MD, Thierry Caus, MD, Sarah Traullé, MD, Maciej Kubala, MD   +3 more
doaj   +1 more source

Advancing cardiac arrhythmia management: The integration of wearable technology and remote monitoring. [PDF]

World J Cardiol
Bokhari SFH, Waseem AB, Raza H, Iqbal A, Javaid S, Idrees B, Saad KAD, Bakht D, Dost W.   +8 more
europepmc   +1 more source

Cardiac arrhythmias during ether anæsthesia [PDF]

, 1963
S.M. HART, R. Bryce‐Smith
openalex   +1 more source

Self‐Disgust, Body‐Related Attentional Bias and Body Dissatisfaction: A Virtual Reality and Eye‐Tracking Exploration

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective This study examines the relationships between self‐disgust, body dissatisfaction (BD), and attentional biases (AB) toward weight‐related body areas, exploring whether self‐disgust predicts attentional avoidance and moderates the relationship between BD and AB.
Mariarca Ascione, Klaske A. Glashouwer, Franck‐Alexandre Meschberger‐Annweiler, María Teresa Mendoza‐Medialdea, Bruno Porras‐Garcia, Marta Ferrer‐Garcia, José Gutierrez‐Maldonado   +6 more
wiley   +1 more source

Krokodil-Associated Cutaneous Ulceration, Cardiac Arrhythmia and Thrombi. [PDF]

Eur J Case Rep Intern Med, 2023
Hussain H, Angly S, Michel G, Garcia E, Fadel A.   +4 more
europepmc   +1 more source

Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis

ESC Heart Failure, EarlyView.
Abstract COVID‐19 vaccines have been linked to myocarditis, which, in some circumstances, can be fatal. This systematic review aims to investigate potential causal links between COVID‐19 vaccines and death from myocarditis using post‐mortem analysis.
Nicolas Hulscher, Roger Hodkinson, William Makis, Peter A. McCullough   +3 more
wiley   +1 more source

Editorial: Personalized care in cardiac arrhythmias: the role of digital platforms in cardiac arrhythmia management. [PDF]

Front Cardiovasc Med
Bakogiannis C, Nedios S, Papageorgiou N, Vassilikos V.   +3 more
europepmc   +1 more source

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Dysregulation of N-terminal acetylation causes cardiac arrhythmia and cardiomyopathy. [PDF]

Nat Commun
Yoshinaga D, Craven I, Feng R, Prondzynski M, Shani K, Tharani Y, Mayourian J, Joseph M, Walker D, Bortolin RH, Carreon CK, Boss B, Upton S, Parker KK, Pu WT, Bezzerides VJ.   +15 more
europepmc   +1 more source

New synthetic cannabinoids and the potential for cardiac arrhythmia risk. [PDF]

J Mol Cell Cardiol Plus, 2023
Hancox JC, Copeland CS, Harmer SC, Henderson G.   +3 more
europepmc   +1 more source